These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29856158)

  • 1. Efficacy of Gaze Photographs in Diagnosing Ocular Myasthenia Gravis.
    Ahn J; Park KS; Kim JS; Hwang JM
    J Clin Neurol; 2018 Jul; 14(3):333-338. PubMed ID: 29856158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SFEMG in ocular myasthenia gravis diagnosis.
    Padua L; Stalberg E; LoMonaco M; Evoli A; Batocchi A; Tonali P
    Clin Neurophysiol; 2000 Jul; 111(7):1203-7. PubMed ID: 10880794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
    Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
    Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of patients with ocular myasthenia gravis - A case series.
    Karni A; Asmail A; Drory VE; Kolb H; Kesler A
    eNeurologicalSci; 2016 Sep; 4():30-33. PubMed ID: 29430546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Usefulness of Anti-acetylcholine Receptor Binding Antibody Testing in Diagnosing Ocular Myasthenia Gravis.
    Chung IY; Sheth SJ; Wells KK; Campbell TG
    J Neuroophthalmol; 2021 Dec; 41(4):e627-e630. PubMed ID: 32868574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia.
    Valko Y; Wirth MA; Fierz FC; Schesny MK; Rosengren S; Schmückle-Meier T; Bockisch CJ; Straumann D; Schreiner B; Weber KP
    Neurology; 2024 May; 102(10):e209395. PubMed ID: 38669629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ocular myasthenia gravis: diagnostic aspects and evolution].
    de Entrambasaguas M; López-Bernabé R; López-Alemany M
    Rev Neurol; 2007 Apr 1-15; 44(7):397-403. PubMed ID: 17420965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study.
    Guo RJ; Gao T; Ruan Z; Zhou HY; Gao F; Xu Q; Yu LP; Wu SD; Lei T; Li HH; Sun C; Zhang M; Gao YW; Lu XD; Tang YL; Tang BL; Huo FY; Zhu Y; Li ZY; Chang T
    Neurol Ther; 2022 Mar; 11(1):73-86. PubMed ID: 34729706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?
    Monte G; Spagni G; Damato V; Iorio R; Marino M; Evoli A
    J Neurol; 2021 May; 268(5):1803-1807. PubMed ID: 33387011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular Myasthenia: Clinical Course and the Diagnostic Utility of Assaying Acetylcholine Receptor Antibodies.
    Behbehani R; Ali A; Al-Moosa A
    Neuroophthalmology; 2022; 46(4):220-226. PubMed ID: 35859633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy and clinical utility of bed side tests versus laboratory tests in the diagnosis of ocular myasthenia.
    Sivakumar P; Tagare S; Kumar M
    Indian J Ophthalmol; 2022 Apr; 70(4):1331-1337. PubMed ID: 35326049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China.
    Ding J; Zhao S; Ren K; Dang D; Li H; Wu F; Zhang M; Li Z; Guo J
    BMC Neurol; 2020 Jun; 20(1):238. PubMed ID: 32527235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-fiber Electromyography in the Extensor Digitorum Communis for the Predictive Prognosis of Ocular Myasthenia Gravis: A Retrospective Study of 102 Cases.
    Guan YZ; Cui LY; Liu MS; Niu JW
    Chin Med J (Engl); 2015 Oct; 128(20):2783-6. PubMed ID: 26481746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis.
    Jacob S; Viegas S; Leite MI; Webster R; Cossins J; Kennett R; Hilton-Jones D; Morgan BP; Vincent A
    Arch Neurol; 2012 Aug; 69(8):994-1001. PubMed ID: 22689047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of Ocular Myasthenia Gravis in an Argentinian Population.
    Aguirre F; Villa AM
    Eur Neurol; 2018; 79(3-4):113-117. PubMed ID: 29428956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic.
    Kısabay A; Özdemir HN; Gökçay F; Çelebisoy N
    Acta Neurol Belg; 2022 Apr; 122(2):337-344. PubMed ID: 33544334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.